SLURP1 and neoplasm: By testing the secondapproach, it was shown that low concentrations of SLURP-1 and doxorubicin havean additive antimigratory effect in vitro(Fig. 2B),as well as anti-tumor and anti-metastastatic effects in vivo(Fig. 3E,F).Previously, it had been shownthrough immunogenicity and toxicity tests that SLURP-1 upon intravenoustreatment was highly safe [22].